SARAH ALLISON WALL MD
Prescription History 1174815708
Internal Medicine - Hematology in Columbus, OH
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SARAH ALLISON WALL MD, an active Hematology specialist practicing in Columbus, OH. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 252 documented patient claims. Among these therapy options, the most frequently utilized medication is Jakafi, which accounts for 128 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other OH PrescribersVs. OH Avg |
|---|---|---|---|
| JakafiRuxolitinib Phosphate | 128 | $17,339.73 | ▲ More than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 128 Medicare prescriptions for Jakafi, about 5.1 times the volume of the typical Ohio prescriber of this medication (25). Medicare paid an average of $17,339.73 per fill, versus $16,386.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 128 30-Day Fills standardized to 30-day supplies 3,840 Days of Medication total across all patients in 2023 | |||
| VonjoPacritinib Citrate | 34 | $23,578.56 | ▲ More than typical |
About Vonjo: This medication is used to treat a certain bone marrow disorder (myelofibrosis). Show more ▾ It works by blocking your body from producing substances called growth factors. Pacritinib belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 34 Medicare prescriptions for Vonjo, about 2 times the volume of the typical Ohio prescriber of this medication (17). Medicare paid an average of $23,578.56 per fill, versus $21,480.20 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34 30-Day Fills standardized to 30-day supplies 1,020 Days of Medication total across all patients in 2023 | |||
| RezurockBelumosudil Mesylate | 22 | $20,805.99▼ below OH avg | ≈ Typical |
About Rezurock: Belumosudil is used to treat a certain problem that may occur after a stem cell transplant (chronic graft-versus-host disease). Show more ▾ Belumosudil belongs to a class of drugs known as kinase inhibitors. It works by blocking some of your immune system's responses which may cause swelling and scarring of certain organs or parts of the body. In 2023, this provider wrote 22 Medicare prescriptions for Rezurock, about 1.2 times the volume of the typical Ohio prescriber of this medication (19). Medicare paid an average of $20,805.99 per fill, versus $23,719.79 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 22 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $8.36 | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 19 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 68% of the volume of the typical Ohio prescriber of this medication (28). Medicare paid an average of $8.36 per fill, versus $5.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29.3 30-Day Fills standardized to 30-day supplies 732 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 15 | $4,593.76 | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 15 Medicare prescriptions for Imatinib Mesylate, about 68% of the volume of the typical Ohio prescriber of this medication (22). Medicare paid an average of $4,593.76 per fill, versus $2,905.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| ScemblixAsciminib Hydrochloride | 12 | $19,192.50 | – No State Data |
About Scemblix: Asciminib is used to treat a certain type of cancer (chronic myeloid leukemia-CML). Show more ▾ Asciminib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 12 Medicare prescriptions for Scemblix. Medicare paid an average of $19,192.50 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $19,192.50 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| IclusigPonatinib Hcl | 11 | $20,528.77▼ below OH avg | ≈ Typical |
About Iclusig: Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. In 2023, this provider wrote 11 Medicare prescriptions for Iclusig, about the same volume as the typical Ohio prescriber of this medication (12). Medicare paid an average of $20,528.77 per fill, versus $25,132.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OH average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| TasignaNilotinib Hcl | 11 | $17,770.64 | ≈ Typical |
About Tasigna: Nilotinib is used to treat a certain type of blood cancer (chronic myelogenous leukemia-CML). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 11 Medicare prescriptions for Tasigna, about 79% of the volume of the typical Ohio prescriber of this medication (14). Medicare paid an average of $17,770.64 per fill, versus $15,353.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average OH prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SARAH ALLISON WALL MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology prescribing approach at this Columbus, OH practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among OH prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
